Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: Event-based disclosure dated January 12, 2026.
Context: The filing serves as a Regulation FD disclosure to distribute an "Investor Update" slide presentation previously presented to the investment community. The presentation covers the Company's business strategy and outlook.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The financial details are contained within the attached Exhibit 99.1 (Investor Update slide presentation), which is incorporated by reference but not included in the text of this Form 8-K.
Material Changes
No material changes to financial results or operations are explicitly detailed in the text of this filing. The document functions as a conduit for the attached presentation materials rather than a report of specific operational changes.
Guidance, Outlook, and Risks
- Outlook: The Company has distributed an Investor Update presentation containing information on its business strategy and outlook.
- Forward-Looking Statements: The filing includes standard disclaimers that statements regarding future expectations, estimates, and projections are subject to risks and uncertainties that may cause actual results to differ materially.
- Risk Factors: Specific risks are not enumerated in this text; investors are directed to the "Risk Factors," "Management's Discussion and Analysis," and "Quantitative and Qualitative Disclosures about Market Risk" sections of the Company's most recent Forms 10-K and 10-Q.
- Legal Status: The information in this Item 7.01 and the attached Exhibit is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor will it be incorporated by reference into Securities Act filings.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Update slide presentation) for specific financial metrics, strategic updates, and guidance not present in the 8-K text.
- Verify the Company's most recent Forms 10-K and 10-Q for detailed risk factors and historical financial performance.
- Confirm the status of the Interim Chief Financial Officer, Mark Frost, who signed the report.
- Check the Company's investor relations website for the full text of the slide presentation referenced in this filing.